Archive
BATTERY 2030+ – large-scale European initiative for battery research starts up
Future batteries need to store more energy, have longer life, and be safer and more environmentally friendly than today's batteries. The European initiative BATTERY 2030+, in which PSI is participating, is intended to help achieve these goals.
Nanostructures with a unique property
Researchers at the Paul Scherrer Institute PSI have for the first time identified special nano-vortices in a material: antiferromagnetic skyrmions.
Customising an electronic material
PSI scientists have investigated a material that could be suitable for future data storage applications. They have manipulated the crystalline structure of their sample while measuring how this affects the material’s magnetic and electronic properties.
Better catalysts for a sustainable bioeconomy
Zeolites are already indispensable additives in the chemical industry – researchers from PSI and ETH Zurich suggest ways to make them still more efficient.
The cold memory of the earth
Within the framework of an international project, researchers from the Paul Scherrer Institute PSI are helping to save a valuable environmental and climatic archive. During an expedition 4,000 metres above sea level on Grand Combin in the Alps, they are drilling ice cores from melting glaciers to preserve them in Antarctica.
«Forschung online erleben»: Mittendrin statt nur dabei
Erstmals Live-Rundgang durch eine Grossforschungsanlage per Video-Stream. Am 9. September haben Interessierte exklusiv die Möglichkeit, sich von Experten des PSI durch den neuen Freie-Elektronen-Röntgenlaser SwissFEL führen zu lassen und zu erfahren, welche Rätsel der Materie und der Natur sich damit lösen lassen.
A question of binding
At PSI, researchers are screening molecule fragments to see if these bind to important proteins of the coronavirus SARS-CoV-2 and thus have the potential to disable it. They are hoping the many individual pieces of information will yield an answer as to what an effective drug might look like.
«We're making SLS fit for the future»
The Swiss Light Source SLS is set to get an upgrade to make excellent research possible in the coming decades as well. Hans Braun, SLS 2.0 project leader, talks about this undertaking in an interview.
Coronavirus advice: Ventilate, ventilate, ventilate!
SARS-CoV-2 might be transmitted via aerosols, that is, through the air. Researchers point this out in the journal Clinical Infectious Diseases. André Prévôt from PSI co-signed the publication. In this interview, he explains which precautionary measures he recommends.
Covid-19 research: Anti-viral strategy with double effect
Frankfurt scientists identify a possible weakness of the SARS-CoV-2 virus. They carried out part of their measurements at PSI's Swiss Light Source SLS. The research results are published this week in the scientific journal Nature.
In search of new physics
With the high-intensity proton accelerator HIPA, the Paul Scherrer Institute generates elementary particles to clarify how the universe is structured. Using pions, muons, and neutrons, the researchers conduct experiments to test the standard model of particle physics.
To the sun and beyond
PSI takes part in space research projects. This not only expands knowledge about our astronomical home, but also reinforces Switzerland's reputation as a reliable developer of sophisticated space equipment.
Patents as trump cards
John Millard is head of Technology Transfer at PSI. Intellectual property also falls within this area. In an interview, he tells how PSI protects its knowledge with patents and, thanks to its patents, further strengthens collaboration with industry and other research institutions.
Research with a patent
At PSI, researchers develop innovative technologies, new biological agents, and more precise measuring instruments. Through this work they not only advance science, but also boost the Swiss economy. The best ideas are protected by patents and make PSI a sought-after partner for industry.
Elucidating the mechanism of a light-driven sodium pump
Researchers at the Paul Scherrer Institute PSI have succeeded for the first time in recording a light-driven sodium pump from bacterial cells in action. The findings promise progress in developing new methods in neurobiology. The researchers used the new X-ray free-electron laser SwissFEL for their investigations.
Life cycle assessment of cars – new web tool helps consumers and researchers
Decision support for car buyers: Researchers at the Paul Scherrer Institute have developed a web tool called the Carculator that can be used to compare the environmental performance of passenger cars in detail.
Long-lived pionic helium: Exotic matter experimentally verified for the first time
Exotic atoms, in which electrons are replaced by other particles, allow deep insights into the quantum world. After eight years, an international group of scientists have succeeded in a challenging experiment conducted at PSI’s pion source: they created an artificial atom called “pionic helium”.
Long-term developments of energy pricing and consumption in industry
Researchers from the Paul Scherrer Institute PSI, on behalf of a research project funded by the Swiss Federal Office of Energy (SFOE), have studied how energy consumption by Swiss industry develops depending on energy prices. One result: Price increases for energy usually affect energy consumption only over the long term.
In search of the lighting material of the future
At the Paul Scherrer Institute PSI, researchers have gained insights into a promising material for organic light-emitting diodes (OLEDs). This new understanding at the atomic level will help to develop new lighting materials that have higher light output and also are cost-efficient to manufacture.
Why Covid-19 hits older people especially hard
The older you are, the higher the risk of dying from a coronavirus infection. G. V. Shivashankar, a group leader at PSI and professor at ETH Zurich, now presents an unusual thesis in a publication in Nature Reviews: that the stiffness of cells might play a decisive role in the course of the disease. In this interview, he explains why.